Asset Dedication LLC reduced its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 18.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,227 shares of the healthcare conglomerate’s stock after selling 2,526 shares during the period. Asset Dedication LLC’s holdings in UnitedHealth Group were worth $5,679,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other large investors have also recently made changes to their positions in the company. International Assets Investment Management LLC increased its holdings in UnitedHealth Group by 78,814.4% in the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after acquiring an additional 5,290,025 shares in the last quarter. Accredited Investors Inc. grew its holdings in shares of UnitedHealth Group by 9,235.4% during the third quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock worth $458,929,000 after buying an additional 776,516 shares in the last quarter. Raymond James & Associates grew its holdings in shares of UnitedHealth Group by 33.1% during the third quarter. Raymond James & Associates now owns 2,361,396 shares of the healthcare conglomerate’s stock worth $1,380,661,000 after buying an additional 587,088 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec grew its holdings in shares of UnitedHealth Group by 129.7% during the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate’s stock worth $601,951,000 after buying an additional 581,324 shares in the last quarter. Finally, State Street Corp grew its holdings in shares of UnitedHealth Group by 1.3% during the third quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock worth $26,626,387,000 after buying an additional 563,554 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at UnitedHealth Group
In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the company’s stock in a transaction on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.33% of the stock is currently owned by insiders.
UnitedHealth Group Stock Down 0.2 %
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period in the prior year, the firm earned $5.83 earnings per share. The business’s quarterly revenue was up 6.8% compared to the same quarter last year. Analysts forecast that UnitedHealth Group Incorporated will post 29.74 earnings per share for the current fiscal year.
UnitedHealth Group Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were paid a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.55%. UnitedHealth Group’s payout ratio is 54.19%.
Wall Street Analyst Weigh In
A number of equities research analysts have recently issued reports on the stock. Morgan Stanley dropped their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Truist Financial dropped their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. KeyCorp reissued an “overweight” rating and issued a $650.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Royal Bank of Canada dropped their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a report on Wednesday, October 16th. Finally, Oppenheimer upped their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus target price of $629.32.
Read Our Latest Stock Analysis on UNH
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
- Five stocks we like better than UnitedHealth Group
- What is Put Option Volume?
- Why Salesforce Stock Could Be at Fresh Highs by February
- 10 Best Airline Stocks to Buy
- Talos Energy: Time to Take a Plunge Ahead of New CEO Appointment?
- Technology Stocks Explained: Here’s What to Know About Tech
- Oklo’s Fuel Partnership Strengthens Bullish Case for Stock
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.